Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Daniel Ooi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Medicine|December 27, 2021
Editorial: The Network of Inflammatory Mechanisms in Kidney Disease: Mechanism and New Therapeutic AgentsYuji Nozaki, Poh-Yi Gan, Joshua Daniel Ooi
Frontiers in Immunology|May 5, 2023
NETosis as an oncologic therapeutic target: a mini reviewSarah Jaboury, Kenny Wang, Kim Maree O'Sullivan, et al.
Frontiers in Immunology|June 18, 2024
Editorial: Innate immunity in vasculitisAlexandre Wagner Silva De Souza, Joshua Daniel Ooi, Durga Prasanna Misra, et al.
Frontiers in Immunology|January 22, 2026
Editorial: Community series: systemic vasculitis: advances in pathogenesis and therapies, volume IIAlexandre Wagner Silva De Souza, Joshua Daniel Ooi, Jun Deng, et al.
Frontiers in Immunology|July 30, 2025
Neutralizing the Th1 effector cytokines, IFN-γ and TNF-α, attenuates established experimental autoimmune anti-myeloperoxidase glomerulonephritisKei Nagai, Daniel Koo Yuk Cheong, Anne Cao Le, et al.
Frontiers in Medicine|February 4, 2022
Patient Survival Between Hemodialysis and Peritoneal Dialysis Among End-Stage Renal Disease Patients Secondary to Myeloperoxidase-ANCA-Associated VasculitisXueqin Wu, Yong Zhong, Ting Meng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 29, 2017
Pathogenic Role for γδ T Cells in Autoimmune Anti-Myeloperoxidase GlomerulonephritisPoh-Yi Gan, Takeshi Fujita, Joshua Daniel Ooi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|December 27, 2021
Editorial: The Network of Inflammatory Mechanisms in Kidney Disease: Mechanism and New Therapeutic AgentsYuji Nozaki, Poh-Yi Gan, Joshua Daniel Ooi
Frontiers in Immunology|May 5, 2023
NETosis as an oncologic therapeutic target: a mini reviewSarah Jaboury, Kenny Wang, Kim Maree O'Sullivan, et al.
Frontiers in Immunology|June 18, 2024
Editorial: Innate immunity in vasculitisAlexandre Wagner Silva De Souza, Joshua Daniel Ooi, Durga Prasanna Misra, et al.
Frontiers in Immunology|January 22, 2026
Editorial: Community series: systemic vasculitis: advances in pathogenesis and therapies, volume IIAlexandre Wagner Silva De Souza, Joshua Daniel Ooi, Jun Deng, et al.
Frontiers in Immunology|July 30, 2025
Neutralizing the Th1 effector cytokines, IFN-γ and TNF-α, attenuates established experimental autoimmune anti-myeloperoxidase glomerulonephritisKei Nagai, Daniel Koo Yuk Cheong, Anne Cao Le, et al.
Frontiers in Medicine|February 4, 2022
Patient Survival Between Hemodialysis and Peritoneal Dialysis Among End-Stage Renal Disease Patients Secondary to Myeloperoxidase-ANCA-Associated VasculitisXueqin Wu, Yong Zhong, Ting Meng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 29, 2017
Pathogenic Role for γδ T Cells in Autoimmune Anti-Myeloperoxidase GlomerulonephritisPoh-Yi Gan, Takeshi Fujita, Joshua Daniel Ooi, et al.
Pageof 1